Literature DB >> 34166264

Pearls: How (and Why) to Use Participatory Language When Communicating with Patients About Osteoarthritis.

Samantha Bunzli1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34166264      PMCID： PMC8277280          DOI： 10.1097/CORR.0000000000001886

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.755


× No keyword cloud information.
  4 in total

Review 1.  Understanding medical symptoms: a conceptual review and analysis.

Authors:  Kirsti Malterud; Ann Dorrit Guassora; Anette Hauskov Graungaard; Susanne Reventlow
Journal:  Theor Med Bioeth       Date:  2015-12

2.  Editor's Spotlight/Take 5: Misconceptions and the Acceptance of Evidence-based Nonsurgical Interventions for Knee Osteoarthritis. A Qualitative Study.

Authors:  Seth S Leopold
Journal:  Clin Orthop Relat Res       Date:  2019-09       Impact factor: 4.176

3.  Three steps to changing the narrative about knee osteoarthritis care: a call to action.

Authors:  J P Caneiro; Peter B O'Sullivan; Ewa M Roos; Anne J Smith; Peter Choong; Michelle Dowsey; David J Hunter; Joanne Kemp; Jorge Rodriguez; Stefan Lohmander; Samantha Bunzli; Christian J Barton
Journal:  Br J Sports Med       Date:  2019-09-04       Impact factor: 13.800

4.  How Do People Communicate About Knee Osteoarthritis? A Discourse Analysis.

Authors:  Samantha Bunzli; Nicholas Taylor; Penny O'Brien; Michelle Dowsey; Jason Wallis; Peter Choong; Nora Shields
Journal:  Pain Med       Date:  2021-05-21       Impact factor: 3.750
  4 in total
  2 in total

Review 1.  Osteoarthritis Treatment Guidelines from Six Professional Societies: Similarities and Differences.

Authors:  Chris Overton; Amanda E Nelson; Tuhina Neogi
Journal:  Rheum Dis Clin North Am       Date:  2022-07-05       Impact factor: 2.032

2.  CORR Insights®: People Have Mixed Reactions to Both Physiological and Psychological Explanations of Disproportionate Pain.

Authors:  Samantha Bunzli
Journal:  Clin Orthop Relat Res       Date:  2022-04-06       Impact factor: 4.755
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.